The impact of the COVID-19 pandemic on the standards of care of patients with lysosomal storage diseases and the needs of their healthcare providers were explored using a 12-question survey. Overall, 80/91 respondents (88%) indicated that the pandemic had negatively affected standards of care. With increased reliance on telemedicine, the respondents highlighted the need for a personalized approach to care, direct and frequent communication with patients, and greater involvement of patients and caregivers. Highlights • The COVID-19 pandemic has changed how physicians and patients interact. • A survey explored the impact of these changes on the care of patients with lysosomal storage diseases. • 88% of respondents noted that the pandemic had affected standards of care. • Increased need for personalized care and direct communication was noted. • Increased reliance on telemedicine was also highlighted.
【저자키워드】 COVID-19, COVID-19, Coronavirus disease 2019, LSD, lysosomal storage disease, Lysosomal storage disease, Fabry Outcome Survey, Gaucher Outcome Survey, Hunter Outcome Survey, Standard of care, ERT, enzyme replacement therapy, FOS, Fabry Outcome Survey, GOS, Gaucher Outcome Survey, HCP, healthcare professional, HOS, Hunter Outcome Survey, IT, information technology, MPS II, mucopolysaccharidosis II, 【초록키워드】 pandemic, Diseases, COVID-19 pandemic, Patient, disease, change, Care, patients, Healthcare provider, physician, approach, greater, affected, indicated, changed, Increased, lysosomal, negatively affected, 【제목키워드】 survey, COVID-19 pandemic, Impact, Patient, Healthcare professional, lysosomal,